Author

Junlian Hu

Institution: Ligand Pharmaceuticals (United States)

Observed institutions: East China University of Science and Technology, Ligand Pharmaceuticals (United States)

OpenAlex ID: A5043826075

A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects

2003 · Michael J. Coghlan, Peer B. Jacobson, et al. · Molecular Endocrinology · 224

A Nonsteroidal Glucocorticoid Receptor Antagonist

2003 · Jeffrey N. Miner, Curtis Tyree, et al. · Molecular Endocrinology · 55

Cell-Specific Activation of the Human Skeletal α-Actin by Androgens

2007 · Mei Hua Hong, Hong Sun, et al. · Endocrinology · 16

An empirical research on the patterns and influencing factors of strategy formation processes

2008 · Yugang Li, Junlian Hu · Frontiers of Business Research in China · 2

NON-Peptidyl Small Molecule EPO Receptor Agonists Are Potent Pathway Selective Inducers of Erythropoiesis.

2010 · Reid P. Bissonnette, Deepa Rungta, et al. · Blood

Works count: 5

Citation count: 297

H-index: 3

I10-index: 3